about
Hepatitis C virus infection protein networkStructure homology and interaction redundancy for discovering virus-host protein interactionsPhEVER: a database for the global exploration of virus-host evolutionary relationshipsVirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networksCharacterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing ParticlesHepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic CellPreferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteinsTh1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C VirusViralORFeome: an integrated database to generate a versatile collection of viral ORFsElucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approachesThe interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replicationGeneration and comprehensive analysis of an influenza virus polymerase cellular interaction networkFlavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screenBenchmarking a luciferase complementation assay for detecting protein complexesMice lacking the MHC class II-associated invariant chainVirus-host interactomics: new insights and opportunities for antiviral drug discoveryHLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study.High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis.[Chikungunya, La Réunion and Mayotte, 2005-2006: an epidemic without a story?].pISTil: a pipeline for yeast two-hybrid Interaction Sequence Tags identification and analysis.When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases.Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication.IRGM is a common target of RNA viruses that subvert the autophagy network.Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1Virus-human cell interactomes.Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo.Early Steps of Jaagsiekte Sheep Retrovirus-Mediated Cell Transformation Involve the Interaction between Env and the RALBP1 Cellular Protein.Hepatitis C virus particles and lipoprotein metabolism.Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAsAn inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection.Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A.Role of nuclear receptors in hepatitis B and C infections.An interdisciplinary approach to controlling chikungunya outbreaks on French islands in the south-west Indian ocean.Protein transfer into human cells by VSV-G-induced nanovesicles.Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes.Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells.The metabolic sensors FXRα, PGC-1α, and SIRT1 cooperatively regulate hepatitis B virus transcription.Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF-β signaling.Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component.
P50
Q24311906-7403B210-8895-413F-91CA-E17208AFC2C8Q24322830-3466B1E5-ACF0-43B0-A08F-11883569145DQ24616591-10A255C7-E28E-44AC-A464-EB96BC98E0C9Q24656219-7A17D1A6-0D91-46AD-A96B-0BFBC111371FQ27472884-37264295-CEA7-407B-A7F9-24B7142A9909Q27478174-37FFBA7C-AFD7-4734-A33B-90785486EF2BQ27481398-BF6BC1AE-5FDC-451A-8F92-315B8367EEC3Q27486041-F55C76C8-C5C4-4054-AC5E-7E4A43357BAFQ27490817-DFAD6572-8AAA-43EB-81E5-D41CD81BA562Q28115639-7630496C-450A-4806-8558-C7CB3084F82AQ28115759-70CD18A3-7D11-4B3F-8A79-98BACB93DB2DQ28118085-81FFB9CA-6431-4363-84EC-F1A261E48032Q28119098-549FB8D1-23BD-4C9E-B4E5-6CDB0D24D917Q28254299-F1CD11BD-1080-411F-9459-78C83D1092FCQ28507606-B8060C00-70AE-4071-B11D-E4F075D4FBEAQ28652236-BECA1277-DF04-4495-B400-D6F6C5A8F9A8Q30403698-045F4E06-5A2B-4D84-B7BB-D526C23B3BFCQ33232238-C9136CC8-76BD-4254-8F9A-3898AFB98B64Q33302281-A61FC685-7A8A-4CD6-9E37-CA54B0057AE7Q33513746-E9D1D9B0-AE32-428B-B4FE-F77737D804F1Q33799911-6AC5D8A2-46C6-4E7F-83E5-7995A550F2C6Q34047120-F46D6D73-D5C8-4AC0-B346-788EA33306BDQ34102728-058B555F-5AA4-44BB-8AC0-F9F3F007E017Q34115503-3E2AC284-3813-4B6D-99B7-42E1DCCE0634Q34118773-98398E25-56FD-43E9-9B08-4F05F8876CB8Q34301275-0D12A56E-F664-495F-8B41-48DCE83DA617Q35914375-B26B681E-570C-4656-97F6-D2338A2081E9Q36054706-1A903DC4-9376-41CA-92DC-E95583ED6ECAQ36144801-1FBDB22C-3A76-4DE3-8B93-881CACADF5F4Q36638199-B3067D9B-05E4-416A-9CC3-FD80DDB91D05Q37595395-3E93573A-9450-45CD-BE09-25E51D845B7FQ37643752-422D7E2A-7625-4DEB-B40D-2573F8D28432Q37840685-61251021-2553-4C60-B10F-F335C7D4D8BFQ38018337-05CB216C-4460-44C2-90B2-31F254060524Q38585869-F1F34BC3-C792-4620-A78F-690F45635394Q38767114-BBE47942-6CD8-4CA3-9C7B-3D8C6CCCFCA3Q38851957-C530B20E-467D-4959-BDC8-F7624BDEF3A4Q39050722-2231BC4F-9714-4486-B2B8-E787EF64A0E2Q39137746-726B7244-3E80-4EBE-8D5E-31595C5A8954Q39410121-0C5F6A7C-BB49-483D-A5D8-6FEAEF6AA246
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
V Lotteau
@ast
V Lotteau
@en
V Lotteau
@es
V Lotteau
@nl
type
label
V Lotteau
@ast
V Lotteau
@en
V Lotteau
@es
V Lotteau
@nl
altLabel
Vincent Lotteau
@en
prefLabel
V Lotteau
@ast
V Lotteau
@en
V Lotteau
@es
V Lotteau
@nl
P106
P31
P496
0000-0003-0997-3282